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Abstract Exercise therapy is generally recommended in
osteoarthritis (OA) of the hip or knee. However, coexisting
disorders may bring additional impairments, which may
necessitate adaptations to exercise for OA of the hip or knee.
For the purpose of developing an adapted protocol for
exercise therapy in OA patients with coexisting disorders,
information is needed on which specific coexisting disorders
in OA are associated with activity limitations and pain.
To describe the relationship between specific coexisting
disorders, activity limitations, and pain in patients with OA
of the hip or knee, a cross-sectional cohort study among 288
older adults (50–85 years of age) with OA of hip or knee was
conducted. Subjects were recruited from three rehabilitation
centers and two hospitals. Demographic data, clinical data,
information about coexisting disorders (i.e., comorbidity and
other disorders), activity limitations (WOMAC: physical
functioning domain), and pain (visual analogue scale (VAS))
were collected by questionnaire. Statistical analysis included
descriptive statistics and multivariate regression analysis.
Coexisting disorders associated with activity limitations were
chronic back pain or hernia, arthritis of the hand or feet,
and other chronic rheumatic diseases (all musculoskeletal
disorders); diabetes and chronic cystitis (non-musculoskeletal
disorders); hearing impairments in a face-to-face conversa-
tion, vision impairments in long distances, and dizziness in
combination with falling (all sensory impairments); and
overweight and obesity. Coexistent disorders associated with
pain were arthritis of the hand or feet, other chronic rheumatic
diseases (musculoskeletal disorders), and diabetes (non-
musculoskeletal disorder). Specific disorders coexisting next
to OA and associated with additional activity limitations and
pain were identified. These coexisting disorders need to be
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addressed in exercise therapy and rehabilitation for patients
with OA of the hip or knee.
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Introduction
Osteoarthritis (OA) is one of the diseases with the highest
rates of comorbidity [1]. Previous studies have reported
comorbidity rates of 68% to 85% [2–5]. Diseases that
frequently occur next to OA are diabetes, hypertension, and
cardiovascular disorders; other disorders, including over-
weight and back pain, occur frequently as well [1, 4, 6].
Thus, coexisting disorders—defined as coexisting diseases
and coexisting other disorders (e.g., overweight)—are
highly prevalent in OA.
Exercise therapy is generally recommended in OA of the
hip or knee: Exercise is effective in reducing activity
limitations and pain in OA [7, 8]. However, coexisting
disorders may bring additional impairments, which neces-
sitate adaptations to the exercise protocol for OA of the hip
or knee. For the future purpose of developing such an
adapted protocol, information is needed on which specific
coexisting disorders in OA are disabling, i.e., which
coexisting disorders are associated with activity limitations
and pain. Coexisting disorders causing activity limitations
and pain are likely to cause restrictions to exercise therapy
as well, necessitating adaptations in the exercise protocol.
Previously, we have reported which coexisting disorders
are associated with additional activity limitations and pain
in OA of hip or knee [5, 9]. In these studies, we used the
Cumulative Illness Rating Scale (CIRS) [10–12] to assess
coexisting disorders. The CIRS yields information on
global categories of coexisting diseases, e.g., ear, eye,
nose, and throat diseases or endocrine and metabolic
diseases. Although quite informative, more detailed infor-
mation on which specific coexisting disorders are disabling
is required in order to be able to develop the exercise
therapy protocol with adaptations for coexisting disorders.
The objective of the study was to describe the relationship
between specific coexisting disorders, activity limitations,
and pain in patients with hip or knee OA.
Methods
Design
The present study is a secondary analysis of previously
reported data [5]. The design of this cross-sectional study is
summarized below. The reader is referred to the original
publication for a more detailed description of the design
[5]. The study was approved by the Medical Ethical
Committee of the VU University Medical Centre, Amster-
dam, the Netherlands.
Study population
Participants were recruited from three rehabilitation centers
and two hospitals (Departments of Orthopedics, Rheuma-
tology, or Rehabilitation). Inclusion criteria were (a)
diagnosis of OA of the hip or knee by medical specialist
according to radiological criteria or clinical criteria of the
American College of Rheumatology [13, 14], (b) 50 years
of age or older, (c) referral to hospital or rehabilitation
center less than a year before inclusion, (d) at least
moderate functional problems (Lequesne algofunctional
index score ≥5) [15], and (e) informed consent. Exclusion
criteria were (a) 85 years of age or older, (b) insufficient
understanding of the Dutch language, and (c) expected
death due to fatal illness within 1 year after inclusion.
Measurements
Patients were invited to a test location. The data used in the
present study were gathered by means of interview
(demographic and clinical data) and questionnaires (activity
limitations, pain, and coexistent disorders). X-rays were
used to evaluate radiological impairment of the hip or knee.
Demographic and clinical data
Demographic and clinical data were collected for each
patient including age, gender, height, weight, location of
OA, duration of complaints, other joint complaints, level of
education, and marital status. Body mass index (BMI) was
calculated (weight/height2). If available, X-rays of the hip
and knee recorded in the year before inclusion were scored
on joint space width and osteophytes, following a stan-
dardized procedure [16, 17]. A 0–3 scale was used for
rating the radiographs: 0=normal; 1=mild or 1–33%
abnormal; 2=moderate or 34–66% abnormal; 3=severe or
67–100% abnormal. From these scores, Kellgren and
Lawrence grades were calculated.
Activity limitations and pain
Activity limitations were measured using the physical
functioning domain of the Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) (range 0–100)
[18, 19]. WOMAC physical functioning score is a
standardized score using the formula: ((68− total score on
the physical functioning domain)×100)/68. A higher score
on this standardized WOMAC stands for fewer activity
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limitations. Pain at the time of assessment was rated on a
visual analogue scale (VAS) (range 0–10). A higher score
on VAS reflects more pain.
Coexisting disorders
Patients indicated the presence or absence of coexisting
disorders in the year prior to the interview, using the list of
the Dutch Bureau of Statistics (CBS). This list describes the
most common chronic diseases and disorders in the Nether-
lands [20]. Based on expert consultation, impairments in
vision and hearing were added to this list. Overweight was
defined as 25 kg/m2≤BMI<30 kg/m2; obesity was defined
as BMI≥30 kg/m2. Coexisting disorders were categorized as
musculoskeletal disorders, non-musculoskeletal disorders,
sensory impairments, and overweight and obesity.
Statistical analyses
The presence of coexisting disorders, activity limitations,
and pain was analyzed using descriptive statistics. Subse-
quent analyses were limited to those disorders that affected
≥5% of the study population. The association between
coexisting disorders (present or absent) and activity
limitations was evaluated in multivariate regression analy-
ses, correcting for age and gender. Similar analyses were
done for the association between coexisting disorders and
pain, correcting for age and gender. An association was
termed significant if the p value was <0.05. For all
analyses, the SPSS (version 14.0) was used [21]
Results
Study population
Initially, 775 patients with osteoarthritis of the hip or knee
that visited the department in the year prior to inclusion
were contacted by mail and were asked to participate in the
study. Of those patients that volunteered (n=364), 288 were
included. Seventy-six patients were excluded because they
did not meet the inclusion criteria. Reasons of exclusion
were age (n=2), language (n=4), less than moderate
functional problems (n=48), and referral longer than 1 year
before inclusion (n=22). Analyses showed that there
were no differences between the group of patients that
were initially contacted (N=775) and the patients that were
included in the study (N=288) with regard to age and
gender. Some differences were found in the location of OA.
Compared to our study population, patients that were
initially contacted suffered less frequently from both hip
and knee OA (6.2%) and more frequently from knee OA
(59.5%) and hip OA (34.3%) [5].
Table 1 shows baseline characteristics of the study
population. The majority of the study population was
female (71,2%), the mean age was 66 (SD=8,7) years.
The largest part of the subjects (48.4%) suffered from knee
OA, 25.1% suffered from hip OA, and 26.5% had both hip
and knee OA. The mean physical functioning score on the
WOMAC was 56.5 (SD=19.6), and the mean pain score on
the VAS was 4.8 (SD=2.6). Most patients (80%) were
recruited from the departments of orthopedics; the other
20% originated from departments of rheumatology and
departments of rehabilitation.
Coexisting disorders
The presence of coexisting disorders in the study popula-
tion is presented in Table 2. Eighteen coexisting disorders
occurred in >5% of the sample (see Table 2). In the
category of musculoskeletal disorders, coexisting condi-
tions occurring in >5% of the patients included chronic
back pain or hernia, 29.5%; arthritis of the hand or feet,
18.4%; and other chronic rheumatic diseases, 10.1%. In the
category of non-musculoskeletal disorders, coexisting con-
ditions occurring in >5% of the patients included hyperten-
sion, 31.9%; asthma or COPD, 15.6%; sinusitis, 12.2%;
diabetes, 9.7%; thyroid disorders, 8.7%; severe cardiac
disorder or coronary disease, 8%; severe bowel disorder,
6.6%; migraine, 6.6%; chronic cystitis, 5.6%; and prolapse
in 8.3% of the female patients. In the category of sensory
impairments, coexisting conditions occurring in >5% of the
patients were hearing impairments in a group conversation,
Table 1 Baseline characteristics (N=288)
Gender: male, n (%) 83 (28.8%)
Age, mean (sd) 66 (8.7)
Body mass index, mean (sd), kg/m2 27.8 (4.5)
Location OA
Knee OA, n (%) 139 (48.4%)
Hip OA, n (%) 72 (25.1%)
Both, n (%) 76 (26.5%)
Duration of complains (years), mean (sd) 9.9 (10.7)
Physical functioning (WOMAC), mean (sd) 56.51 (19.85)
Pain (VAS), mean (sd) 4.81 (2.56)
Radiological impairment kneea
K&L grade ≥2; n (%) 118 (95.2)
Radiological impairment hipb
K&L grade ≥2; n (%) 83 (97.6)
N, n number, sd standard deviation, OA osteoarthritis, WOMAC,
Western Ontario and McMasters Universities Osteoarthritis Index,
VAS visual analogue scale
aN=138 (from only a part of the included patients X-rays were
available)
bN=90 (from only part of the included patients X-rays were available)
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31.5%; vision impairments in short distances and long
distances, 26.8% and 11.5%, respectively; and dizziness in
combination with falling, 8.3%. Overweight and obesity
occurred in 51.7% and 23.9%, respectively.
Association between coexisting disorders and activity
limitations
Table 3 shows the relationship between specific coexisting
disorders and activity limitations. Significantly more
activity limitations were found in OA patients with
chronic back pain or hernia (p<0.05), arthritis of the hand
or feet (p<0.05), and other chronic rheumatic diseases (p<
0.05) (all in the category of musculoskeletal disorders);
with diabetes (p<0.05) and chronic cystitis (p<0.05)
(category of non-musculoskeletal disorders); with hearing
impairments in a face-to-face conversation (p<0.05),
vision impairments in long distances(p<0.05), and dizzi-
ness in combination with falling (p<0.05) (category of
sensory impairments); and with overweight (p<0.01) and
obesity (p<0.05).
Association between coexisting disorders and pain
Table 3 also shows the relationship between coexisting
disorders and pain. Arthritis of the hand or feet (p<0.01)
and other chronic rheumatic diseases (p<0.05) (category of
musculoskeletal disorders) and diabetes (p<0.05) (category
of non-musculoskeletal disorders) were found to be
significantly associated with more pain.
Present n (%)
Musculoskeletal disorders
Chronic back pain (>3 month) or hernia 85 (29.5)
Arthritis of the hands or feet 53 (18.4)
Other chronic rheumatic diseases (>3 month) 29 (10.1)
Non-musculoskeletal disorders
Asthma or COPD 45 (15.6)
Sinusitis 35 (12.2)
Severe cardiac disorder or coronary disease 23 (8)
Hypertension 92 (31.9)
(Consequences of) a stroke 6 (2.1)
Peptic ulcer or duodenal ulcer disease 10 (3.5)
Severe bowel disorder (>3 month) 19 (6.6)
Gallstones or inflammation of the gall bladder 6 (2.1)
Liver disorder or cirrhosis of the liver 0 (0)
Kidney stones (calculus renalis) 7 (2.4)
Severe kidney disorder 2 (0.7)
Chronic cystitis 16 (5.6)
Prolapse (only females, N=205) 17 (8.3)
Diabetes 28 (9.7)
Thyroid disorders 25 (8.7)
Epilepsy 2 (0.7)
Migraine 19 (6.6)
Severe skin disease 4 (1.4)
Cancer and malignant diseases 7 (2.4)
Sensory impairments
Hearing impairments in a group conversation (N=286) 90 (31.5)
Hearing impairments in a face-to-face conversation (N=287) 22 (7.7)
Vision impairments in short distances (N=287) 77 (26.8)
Vision impairments in long distances (N=287) 33 (11.5)
Dizziness in combination with falling 24 (8.3)
Overweight and obesity (N=285)
Overweight (25≤BMI<30) 149 (51.7)
Obesity (BMI≥30) 68 (23.9)
Table 2 Presence of coexisting
disorders
N=288, unless otherwise stated.
Data in italics are present in
>5%
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Table 3 Association between coexisting disorders, activity limitations, and pain
Activity limitations (WOMAC) Pain (VAS)
Musculoskeletal disorders
Chronic back pain (>3 month) or hernia
Present (mean (SD))a 51.7 (18.2) 5.0 (2.5)
Absent (mean (SD))a 58.5 (20.2) 4.7 (2.5)
B (95% CI)b −6.4 (−11.5; −1.4)* 0.3 (−0.4; 1.0)
R2 0.033 0.008
Arthritis of hands or feet
Present (mean (SD))a 50.1 (20.3) 5.8 (2.5)
Absent (mean (SD))a 57.9 (19.5) 4.6 (2.5)
B (95% CI)b −7.4 (−13.4; −1.5)* 1.2 (0.4; 1.9)**
R2 0.032 0.037
Other chronic rheumatic diseases (>3 month)
Present (mean (SD))a 47.3 (18.3) 5.9 (2.6)
Absent (mean (SD))a 57.5 (19.8) 4.7 (2.5)
B (95% CI)b −10.0 (−17.6; −2.4)* 1.1 (0.1; 2.1)*
R2 0.035 0.023
Non-musculoskeletal disorders
Asthma or COPD
Present (mean (SD))a 55.2 (19.1) 4.8 (2.6)
Absent (mean (SD))a 56.7 (20.0) 4.8 (2.6)
B (95% CI)b −1.7 (−8.0; 4.7) 0.0 (−0.8; 0.9)
R2 0.012 0.005
Sinusitis
Present (mean (SD))a 54.5 (15.8) 4.9 (2.6)
Absent (mean (SD))a 56.8 (20.4) 4.8 (2.6)
B (95% CI)b −2.0 (−9.1; 5.1) 0.1 (−0.8; 1.0)
R2 0.012 0.006
Severe cardiac disorder or coronary disease
Present (mean (SD))a 51.2 (20.6) 5.1 (2.8)
Absent (mean (SD))a 57.0 (19.8) 4.8 (2.6)
B (95% CI)b −5.5 (−14.1; 3.1) 0.4 (−0.7; 1.6)
R2 0.012 0.008
Hypertension
Present (mean (SD))a 55.8 (21.9) 4.9 (2.5)
Absent (mean (SD))a 56.8 (18.8) 4.8 (2.6)
B (95% CI)b −0.6 (−5.6; 4.5) 0.3 (−0.4; 0.9)
R2 0.012 0.007
Severe bowel disorder (>3 month)
Present (mean (SD))a 54.3 (20.3) 4.5 (3.2)
Absent (mean (SD))a 56.7 (19.9) 4.8 (2.5)
B (95% CI)b −2.0 (−11.3; 7.2) −0.4 (−1.6; 0.8)
R2 0.012 0.007
Chronic cystitis
Present (mean (SD))a 45.2 (17.6) 5.4 (2.9)
Absent (mean (SD))a 57.2 (19.8) 4.8 (2.5)
B (95% CI)b −10.8 (−20.9; −0.7)† 0.7 (−0.6; 2.1)
R2 0.027 0.01
Prolapse (females only)
Present (mean (SD))a 47.0 (22.0) 5.2 (2.9)
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Table 3 (continued)
Activity limitations (WOMAC) Pain (VAS)
Absent (mean (SD))a 56.4 (19.7) 4.8 (2.6)
B (95% CI)b −9.0 (−18.9; 0.9)*** 0.4 (−0.9; 1.7)
R2 0.03 0.005
Diabetes
Present (mean (SD))a 49.5 (18.2) 5.9 (2.2)
Absent (mean (SD))a 57.3 (19.9) 4.7 (2.6)
B (95% CI)b −8.2 (−15.9; −0.4)* 1.2 (0.2; 2.2)*
R2 0.026 0.024
Thyroid disorders
Present (mean (SD))a 51.4 (22.6) 5.6 (2.8)
Absent (mean (SD))a 57.0 (19.6) 4.7 (2.5)
B (95% CI)b −5.8 (−14.2; 2.6) 1.1 (0.0; 2.1)***
R2 0.018 0.018
Migraine
Present (mean (SD))a 56.6 (20.8) 4.5 (2.6)
Absent (mean (SD))a 56.5 (19.8) 4.8 (2.6)
B (95% CI)b 0.1 (−9.2; 9.5) −0.4 (−1.6; 0.8)
R2 0.012 0.007
Sensory impairments
Hearing impairments in a group conversation
Present (mean (SD))a 55.4 (19.1) 4.6 (2.7)
Absent (mean (SD))a 57.0 (20.2) 4.9 (2.5)
B (95% CI)b −0.9 (−6.0; 4.2) −0.3 (−0.9; 0.4)
R2 0.011 0.004
Hearing impairments in a face-to-face conversation
Present (mean (SD))a 46.7 (19.9) 5.6 (2.8)
Absent (mean (SD))a 57.2 (19.7) 4.8 (2.5)
B (95% CI)b −9.6 (−18.4; −0.8)* 1.0 (−0.1; 2.2)***
R2 0.027 0.016
Vision impairments in short distances
Present (mean (SD))a 54.1 (19.8) 5.0 (2.6)
Absent (mean (SD))a 57.3 (19.8) 4.8 (2.6)
B (95% CI)b −2.9 (−9.1; 2.3) 0.3 (−0.4; 1.0)
R2 0.016 0.007
Vision impairments in long distances
Present (mean (SD))a 47.6 (19.1) 5.2 (2.5)
Absent (mean (SD))a 57.6 (19.7) 4.8 (2.6)
B (95% CI)b −9.0 (−16.3; −1.6)* 0.6 (−0.4; 1.6)
R2 0.031 0.01
Dizziness in combination with falling
Present (mean (SD))a 45.4 (23.4) 5.7 (2.9)
Absent (mean (SD))a 57.5 (19.2) 4.7 (2.5)
B (95% CI)b −11.2 (−19.6; −2.8)** 1.1 (0.0; 2.2)***
R2 0.035 0.019
Weight
Overweight (25≤BMI<30)
Present (mean (SD))a 54.7 (19.1) 4.9 (2.6)
Absent (mean (SD))a 62.7 (19.0) 4.4 (2.6)
B (95% CI)b −8.0 (−13.7; −2.4)** 0.5 (−0.3; 1.2)
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Discussion
The aim of this study was to describe the relationship
between specific coexisting disorders, activity limitations,
and pain in patients with OA of the hip or knee. We have
previously reported that “symptoms of other musculoskel-
etal disorders” occur frequently in OA [5]: We have now
found chronic back pain or hernia, arthritis of the hands or
feet, and other chronic rheumatic diseases to be associated
with activity limitations. In our previous study, we found
“endocrine and metabolic diseases” to be associated with
activity limitations: We now discovered that this applies to
diabetes. We also found “other urogenital diseases” to be
associated with activity limitations [5]: We now discovered
that this applies in particular to chronic cystitis. Previously,
we found “ear, eye, nose, and throat diseases” to be
associated with activity limitations [5]: We have now
observed that this applies in particular to hearing impair-
ments in a face-to-face conversation and vision impair-
ments in long distances. We also found dizziness in
combination with falling to be associated with activity
limitations. Finally, overweight and obesity were found to
be related to activity limitations.
Regarding coexistent disorders and pain, we have now
found arthritis of the hands or feet and other chronic
rheumatic diseases to be associated with pain. Previously
we did not find a relationship between endocrine and
metabolic diseases and pain [5]; however, we now found an
association between diabetes and pain.
Coexisting disorders may bring additional impairments,
which necessitate adaptations to exercise for patients with
OA of the hip or knee. For the future purpose of developing
a protocol for exercise in OA patients with coexisting
disorders, information is needed on which specific coexist-
ing disorders in OA are associated with activity limitations
and pain. The present study brings highly relevant new
information in this respect. To our knowledge, this is the
first study suggesting that hearing impairments, vision
impairments, dizziness, and chronic cystitis need to be
addressed in order to optimize functioning of patients with
OA. Only Peters et al. have previously reported on the (near
significant) relationship between eye diseases and future
disability in patients with knee OA [22]. The present results
shows that coexisting sensory impairments in hearing,
vision, and balance, as well as motor impairments in
bladder control (in the case of cystitis), have impact on
functioning of patients with OA of the hip or knee:
Apparently, these impairments need to be addressed in the
rehabilitation of OA patients.
It is well known that OA is associated with other
musculoskeletal disorders [23]. In contrast, very little
information is available on the impact of coexisting
musculoskeletal disorders on activity limitations and pain.
Cimmino et al. describe greater pain in patients with
generalized OA than in patients with hip or knee OA alone
[24]. The present study found an association between
arthritis of the hand or feet, “other” chronic rheumatic
diseases, chronic back pain or hernia, and activity limi-
tations. We also found a relationship between arthritis of the
hand or feet, other chronic rheumatic diseases, and pain.
The present study confirms earlier observations on the
impact of diabetes, overweight, and obesity on activity
limitations in OA. Diabetes causes physiological restric-
tions to exercise therapy [25], whereas overweight and
obesity introduce behavioral restrictions to exercise [26].
Combining exercise therapy with a weight loss program has
been shown to result in moderately improved outcome,
compared to exercise therapy alone [27]. Further work on
adaptations to exercise therapy for OA patients with
diabetes, overweight, and obesity is urgently required,
because of the high prevalence and the functional impact
of these coexisting disorders.
In our previous study, we found 54% of the study
population to have cardiac diseases, and a significant
relationship with activity limitations was found [5].
Caporali et al. found cardiac diseases (myocardial infarction
Table 3 (continued)
Activity limitations (WOMAC) Pain (VAS)
Obesity (BMI≥30)
Present (mean (SD))a 54.1 (21.4) 5.0 (2.6)
Absent (mean (SD))a 62.7 (19.0) 4.4 (2.6)
B (95% CI)b −8.6 (−15.3; −1.9)* 0.6 (−0.3; 1.5)
R2 0.041 0.014
WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, VAS visual analogue scale, B regression coefficient, 95% CI 95%
confidence interval
*p<0.05; **p<0.01; ***p<0.1
a Observed value
b Adjusted value for age and sex
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and/or angina pectoris) to influence pain, quality of life, and
joint function in OA patients [4]. Ettinger et al. also
describe a higher likelihood of disabilities in OA patients
with heart diseases [28]. In the present study, no significant
relationship was found between cardiac diseases and
activity limitations or pain. A likely explanation is that
subjects rated the presence of “severe heart diseases or
coronary diseases.” This item might have implicated a too
serious stage of disease, causing us to miss patients with
mild or moderate heart disease. Despite our present results,
adaptations for cardiac disease in exercise therapy for OA
patients seem to be required.
The number of coexisting disorders associated with
activity limitations (n=10) was larger than the number of
coexisting disorders associated with pain (n=3). It seems
that coexisting disorders easily impact on activity limita-
tions, while the impact on pain is less strong. Future
research is needed to elucidate the mechanisms of how
coexisting disorders have an impact on activity limitations
and pain. This research may also clarify the differential
impact of coexisting disorders on activity limitations and
pain.
Some limitations of the present study need to be
discussed. Firstly, we relied on self-report to assess
coexisting disorders, instead of medical record review.
However, self-reported coexisting disorders tend to corre-
spond rather well with coexisting disorders derived from
medical record review [29]: The percentage of agreement
exceeded 90% for all coexisting disorders except for
tumors; the kappa statistic ranged from 0.35 to 0.85,
reflecting fair to substantial agreement. Fair agreement
(kappa <0.40) was found for ulcer disease, end organ
damage resulting from diabetes, and connective tissue
disease (not assessed in the present study); substantial
agreement (kappa >0.60) was found for myocardial
infarction, stroke, and renal disease. Thus, self-report on
coexisting disorders seems to be valid, with some excep-
tions noted above. Secondly, in assessing coexistent
disorders, we used the list of the Dutch Bureau of Statistics
(CBS). Unfortunately, this list did not include psychiatric
disorders. From previous studies, it is known that depres-
sion plays an important role in developing activity
limitations [30, 31]. Thirdly, patients included in this study
were recruited from hospitals and rehabilitation centers;
these patients may have received some form of rehabilita-
tion. Thus, the results of the present study cannot be
generalized to the general population suffering from OA.
Nevertheless, the results are applicable to the group of
patients consulting in hospitals and rehabilitation centers:
This is a highly relevant group. Fourthly, the study focused
on patients with OA of the hip or knee. We did not have
information on a reference group of subjects without OA or
subjects with another index disease. In subjects without OA
and subjects with another index disease, comorbidity is
likely to be associated with activity limitations and pain as
well. In future studies, it would be interesting to compare
impact of comorbidity in OA patients and other subjects.
Finally, we did not adjust the analysis for multiple
comparisons: This could easily result in false-negative errors
(type II errors) because of the limited number of subjects
with a specific coexisting disorder. It is acknowledged that
this may have introduced some risk of false-positive errors
(type I errors).
In conclusion, specific disorders coexisting next to OA
and associated with additional activity limitations and pain
were identified. These coexisting disorders need to be
addressed in exercise therapy and rehabilitation for patients
with OA of the hip or knee.
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